Hypothermic renal protection using cold histidine-tryptophan-ketoglutarate solution perfusion in suprarenal aortic surgery.
We examined data of 21 patients who were treated with selective perfusion of both renal arteries with 500 mL of 8 degrees C histidine-tryptophan-ketoglutarate (HTK) solution each for renal protection during aortic surgery. Only the data from aortic surgeries with unavoidable suprarenal aortic cross-clamping for juxtarenal or suprarenal abdominal aortic aneurysms (AAAs) or high Leriche syndrome accompanied with stenosis of renal arteries are presented. Five patients underwent immediate surgery because of perforation of an AAA; the other 16 patients went through elective surgeries. In three cases (14%) stenosis of the renal arteries was diagnosed; nevertheless, implantation of an aortorenal bypass was necessary in seven patients. In total, 14 aortorenal bypasses were implanted (five venous grafts and nine prosthesis grafts). Four (19%) patients needed catecholaminergic support to establish stable circulatory conditions; in two (9%) of these cases additional ischemia of the colon was observed and sigmoidectomy was performed. All of these four patients underwent immediate surgery, and one died after surgery because of severe sepsis. In four cases postsurgical renal insufficiency was observed. Three of these patients were admitted for emergency surgery because of their hemodynamic situation due to perforation of the AAA. None of the patients needed chronic dialysis after surgery. Whereas in all patients who underwent elective surgery the renal function remained stable as judged by postoperative serum creatinine values, in five out of seven patients with aortorenal bypass surgery the renal function improved. Perfusion with cold HTK solution offers an additional procedure to protect renal function in patients undergoing elective surgery with suprarenal cross-clamping of the aorta.
Department of Cardiothoracic and Vascular Surgery, Georg-August-University Goettingen, Germany. schmitto@med.uni-goettingen.de
Jan D
JD
Schmitto
Sheila
S
Fatehpur
Hossein
H
Tezval
Aron F
AF
Popov
Ralf
R
Seipelt
Friedrich A
FA
Schöndube
Masoud
M
Mirzaie
D000368:Aged; D001012:Aorta, Abdominal / Q000601:surgery*; D017544:Aortic Aneurysm, Abdominal / Q000150:complications / Q000601:surgery; D019917:Blood Vessel Prosthesis Implantation; D002314:Cardioplegic Solutions; D003404:Creatinine / Q000097:blood; D005260:Female; D005947:Glucose; D006801:Humans; D007036:Hypothermia, Induced; D007668:Kidney / Q000098:blood supply* / Q000503:physiopathology; D007925:Leriche Syndrome / Q000150:complications / Q000601:surgery; D008297:Male; D008353:Mannitol; D011189:Potassium Chloride; D011343:Procaine; D012078:Renal Artery Obstruction / Q000150:complications; D051437:Renal Insufficiency / Q000209:etiology / Q000517:prevention & control; D014656:Vascular Surgical Procedures / Q000009:adverse effects
C039984:Bretschneider cardioplegic solution; D002314:Cardioplegic Solutions; D008353:Mannitol; D011343:Procaine; D011189:Potassium Chloride; D003404:Creatinine; D005947:Glucose